TotalMarketCap

Fulgent Genetics

FLGTNasdaq United StatesHealth CareMedical Specialities

Market cap

$510.959 M

$18.57 -5.64%

Close of 6 Nov 2026

As of 6 Nov 2026, Fulgent Genetics (FLGT) has a market capitalization of $511.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$322.7M

#2086 by revenue

Earnings

-$60.5M

Loss-making

Shares outstanding

27,939,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →
  1. #30Castle BiosciencesCSTL$1.05B
  2. #31YD BioYDES$511.4M
  3. #32Fulgent GeneticsFLGT$511.0M
  4. #33TriSalus Life SciencesTLSI$217.4M
  5. #34BiodesixBDSX$211.0M

What if Fulgent Genetics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,026,225

Per share 55,263× higher

Bitcoin $1.53T

$55,527.23

Per share 2,990× higher

Apple $5.02T

$182,290.72

Per share 9,816× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Fulgent Genetics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.